Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells

Cytokine

Volumn 60, Issue 1, 2012, Pages 197-204

  Rizzo, Antonietta ^a   Bevilacqua, Nazario ^a,b   Guida, Luigi ^a   Annunziata, Marco ^a   Romano Carratelli, Caterina ^a   Paolillo, Rossella ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Cytokines; Human periodontal ligament cells; Resveratrol

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NITRIC OXIDE; NITRITE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PERIODONTAL LIGAMENT; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NITRIC OXIDE; PERIODONTAL LIGAMENT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PORPHYROMONAS GINGIVALIS;

EID: 84865428973     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.004     Document Type: Article

References (57)

1. Kornman K.S., Page R.C., Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 1997, 2000(14):33-53.
2. Ebersole J.L., Taubman M.A. The protective nature of host responses in periodontal diseases. Periodontology 1994, 2000(5):112-141.
3. Okada H., Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998, 9:248-266.
4. Cochran D.L., Wozney J.M. Biological mediators for periodontal regeneration. Periodontology 1999, 2000(19):40-58.
5. Dale B.A. Periodontal epithelium: a newly recognized role in health and disease. Periodontology 2002, 2000(30):70-78.
6. Teng Y.T. Protective and destructive immunity in the periodontium: Part 1 - Innate and humoral immunity and the periodontium. J Dent Res 2006, 85:198-208.
7. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Jr R.L. Kent. Microbial complexes in subgingival plaque. J Clin Periodontol 1998, 25:134-144.
8. Lamont R.J., Jenkinson H.F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998, 62:1244-1263.
9. Howell T.H., Martuscelli G., Oringer J. Polypeptide growth factors for periodontal regeneration. Curr Opin Periodontol 1996, 3:149-156.
10. King G.N., Cochran D.L. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J Periodontol 2002, 73:925-936.
11. Takayama S., Murakami S., Shimabukuro Y., Kitamura M., Okada H. Periodontal regeneration by FGF-2 (bFGF) in primate models. J Dent Res 2001, 80:2075-2079.
12. Kantarci A., Hasturk H., Van Dyke T.E. Host-mediated resolution of inflammation in periodontal diseases. Periodontology 2006, 2000(40):144-163.
13. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992, 18:1-29.
14. Willett W.C. Diet and health: what should we eat?. Science 1994, 264:532-537.
15. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493-506.
16. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 2002, 957:210-229.
17. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
18. Bi X.L., Yang J.Y., Dong Y.X., Wang J.M., Cui Y.H., Ikeshima T., et al. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005, 5:185-193.
19. DeGroote M.A., Fang C.F. Ferric antimicrobial properties of nitric oxide. Nitric oxide and infection 2000, 231-261. Kluwer Academic Plenum, New York, NY. F.C. Fang (Ed.).
20. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97:8841-8848.
21. Miesel R., Zuber M. Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases. Inflammation 1993, 17:283-294.
22. Stenson W.F. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl 1990, 172:13-18.
23. Klimpel G.R., Asuncion M., Haithcoat J., Niesel D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 1995, 63:1134-1147.
24. Kornman K.S. Controlled-release local delivery antimicrobials in periodontics: prospects for the future. J Periodontol 1993, 64:782-791.
25. Kurumatani M., Fujita R., Shoji A. Analysis of polyphenols from hop bract region using CCC. J Liq Chromatogr Relat Technol 2005, 28:1971-1983.
26. Darveau R.P., Hancock R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983, 155:831-838.
27. Eze M.O., Yuan L., Crawford R.M., Paranavitana C.M., Hadfield T.L., Bhattacharjee A.K., et al. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infect Immun 2000, 68:257-263.
28. Tatakis D.N., Kumar P.S. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005, 49:491-516.
29. López N.J. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis. J Periodontology 2000, 71:948-954.
30. Cazalis J., Tanabe S., Gagnon G., Sorsa T., Grenier D. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation 2009, 32:130-137.
31. Tombola F., Campello S., De Luca L., Ruggiero P., Del Giudice G., Papini E., et al. a toxin secreted by the gastric pathogen Helicobacter pylori. FEBS Lett 2003, 543:184-189.
32. Chen J.H., Tipoe G.L., Liong E.C., So H.S., Leung K.M., Tom W.M., et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 2004, 80:742-751.
33. Poussier B., Cordova A.C., Becquemin J.P., Sumpio B.E. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 2005, 42:1190-1197.
34. Das S., Das D.K. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 2007, 6:168-173.
35. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006, 72:1439-1452.
36. Krehmeier U., Bardenheuer M., Voggenreiter G., Obertacke U., Schade F.U., Majetschak M. Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells. J Infect Chemother 2002, 8:194-197.
37. Gidday J.M., Park T.S., Shah A.R., Gonzales E.R. Modulation of basal and post-ischemic leukocyte-endothelial adherence by NO. Stroke 1998, 29:1423-1429.
38. Stoclet J.C., Muller B., Andriantsitohaina R., Kleschyor A. Over-expression of NO in pathophysiology of blood vessels. Biochemistry 1998, 63:826-832.
39. 2-induced apoptosis and expression of SIRTs in H9c2cells. J Cell Biochem 2009, 107:741-747.
40. Notas G., Nifli A.P., Kampa M., Vercauteren J., Kouroumalis E., Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta 2006, 1760:1657-1666.
41. De la Fuente M., Victor V.M. Anti-oxidants as modulators of immune function. Immunol Cell Biol 2000, 78:49-54.
42. Paolillo R., Carratelli C.R., Rizzo A. Effect of resveratrol and quercetin in experimental infection by Salmonella enterica serovar Typhimurium. Int Immunopharmacol 2011, 11:149-156.
43. Chiang C.Y., Kyritsis G., Graves D.T., Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 1999, 67:4231-4236.
44. Gemmell E., Marshall R.I., Seymour G.J. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology 1997, 2000(145):112-143.
45. Gamonal J., Acevedo A., Bascones A., Jorge O., Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000, 71:1535-1545.
46. Roberts F.A., Hockett R.D., Bucy R.P., Michalek S.M. Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiol Immunol 1997, 12:336-344.
47. Gao X., Xu Y.X., Janakiraman N., Chapman R.A., Gautam S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol 2001, 62:1299-1308.
48. Marier J.F., Chen K., Prince P., Scott G., del Castillo J.R., Vachon P. Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner. Can J Vet Res 2005, 69:151-154.
49. Holt S.C., Kesavalu L., Walker S., Genco C.A. Virulence factors of Porphyromonas gingivalis. Periodontology 1999, 2000(20):168-238.
50. Takahashi K., Takashiba S., Nagai A., Takigawa M., Myoukai F., Kurihara H., et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J Periodontol 1994, 65:147-153.
51. Löwik C.W., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O.L., Aarden L.A., et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989, 162:1546-1552.
52. Crabtree J.E. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996, 10:29-37.
53. Foryst-Ludwig A., Neumann M., Schneider-Brachert W., Naumann M. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 2004, 316:1065-1072.
54. Madianos P.N., Bobetsis A., Kinane D.F. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005, 32:57-71.
55. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004, 287:L774-L783.
56. Horwood N.J., Elliott J., Martin T.J., Gillespie M.T. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001, 166:4915-4921.
57. Yamada N., Niwa S., Tsujimura T., Iwasaki T., Sugihara A., Futani H., et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 2002, 30:901-908.